Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced participation in an upcoming panel discussion highlighting the potential role of Actinium's products in the treatment of older refractory/relapsed acute myeloid leukemia ... (more)
http://ift.tt/1qySpIr
http://ift.tt/1qySpIr
No comments:
Post a Comment